BR vs EBS
Broadridge Financial Solutions Inc (BR) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
BR currently screens at market cap $17.65B and trailing P/E 16.3. EBS currently screens at market cap $416.4M.
Not investment advice. Open the BR and EBS stock pages for the full models.
Not investment advice.